Receipt date: 03i02/201‘7
`
`153§6073 -= GM}: 3735
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Field
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`'“FORMAT'OND'SCLOSURE
`STATEMENT BYAPPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Attorney Docket Number 066964-8034.USOO
`
`W Z
`"
`'
`Art Unit —
`_—
`
`
`
`Examiner Cite
`.
`.
`*
`lnItIal
`No
`
`Patent Number
`
`Kind
`Code
`
`1
`
`Issue Date
`
`Name of Patentee or Applicant of cited
`Document
`
`
`
`Pages, Columns, Lines,
`Where Relevant
`Passages or Relevant
`Figures Appear
`
`U.S. PATENTS
`
`-———-
`-———-
`_-_—
`-———-
`_-_—
`_-——
`-———-
`
`-———-
`-———-
`-———-
`
`-———-
`
`U.S. PATENT APPLICATION PUBLICATIONS
`
`
`
`Pages, Columns, Lines,
`
`Where Relevant
`Passages or Relevant
`Figures Appear
`
` .20010031906
`
`Publication Number
`
`KInd 1 Publication Date Name of Patentee or Applicant of cIted
`Code
`Document
`
`_2001-10-18 lshikawaetal.
`
`66964-8034.USOO/134613923.1
`
`ALL REFERENCES CONSEDEEEE EXCEPT WHERE LINED THROUGH,
`
`IE.G.G/
`
`

`

`Receipt date: 03/92/2017
`
`15396G73 -= GM)": 3735
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Field
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`'“FORMAT'OND'SCLOSURE
`STATEMENT BYAPPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Attorney Docket Number 066964-8034.USOO
`
`W Z
`"
`'
`Art Unit —
`——
`
`II—__
`
`u—-——
`
`n—-——
`u—-——
`
`20
`
`21
`
`22
`
`FOREIGN PATENT DOCUMENTS
`
`
`
`Examiner Cite
`lnitial*
`No
`
`Foreign Document
`Number3
`
`.
`.
`Country Kind
`Code2
`Code4 PUb'mat'm Date
`
`Name of Patentee or Applicant of
`cited Document
`
`Pages, Columns,
`Lines, Where Relevant
`Passages or Relevant
`Figures Appear
`
`.2002025675
`2003090863
`
`--2002-03-28 Havel et al.
`2003-11-06 MCU-Betechnology Co.,
`Ltd.
`
`66964-8034.USOO/134613923.1
`
`ALL REFERENCES CONSEDEEEE EXCEPT WHERE LINED THROUGH,
`
`/S.G.G/
`
`
`
`

`

`Receipt: date: 03i02/201‘7
`
`153§6073 -= GM}: 3735
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Field
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`'“FORMAT'OND'SCLOSURE
`STATEMENT BYAPPLICANT
`(Not for submission under 37 CFR 1.99)
`
`W Z
`"
`'
`Art Unit —
`——
`
`Attorney Docket Number 066964-8034.U800
`
`
`1625-1636.
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Include name ofthe author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book,
`magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or
`country where published.
`
`IZUMIYA, et al., “Fast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves
`Metabolic Parameters in Obese Mice,” Cell Metab. 2008 February: 7(2): 159-172.
`
`LIN, et al., “Functional Magnetic Stimulation: A New Modality for Enhancing Systemic
`Fibrinolysis,” Arch Phys Med Rehabil Vol 80, May 1999, pp. 545-550.
`
`POLK, “Therapeutic Applications of Low-Frequency Sinusoidal and Pulsed Electric and
`Magnetic Fields,” The Biomedical Engineering Handbook, Volume 1, 2000, Second edition, pp.
`
`EXAMINER SIGNATURE
`
`03202917
`Date Considered
`SAMUEL G GILBERT/
`Examiner Signature
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line
`through a citation if not in conformance and not considered. Include copy ofthis form with next communication to
`applicant.
`
`1 See Kind Codes of USPTO Patent Documents at WWWUSPTQGOV or MPEP 901.04. 2 Enter office that issued the document, by the two-
`Ietter code (WIPO Standard ST.3). 3 For Japanese patent documents, the indication of the year ofthe reign ofthe Emperor must precede the
`serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place
`a check mark here if English language translation is attached.
`
`66964-8034.USOO/134613923.1
`
`ALL REFERENCES CONSEDEEEE EXCEPT WHERE LINED THROUGH,
`
`IS.G.G/
`
`

`

`Receipt date: 03/02/2017
`
`153§6073 -= GM}: 3735
`
`Doc code: IDS
`Doc description: Information Disclosure Statement (IDS) Field
`
`PTO/SB/08a (01-10)
`Approved for use through 07/31/2012. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`'“FORMAT'OND'SCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`Application Number
`
`15/396,073
`
`Filing Date
`
`2016-12-30
`
`Art Unit —
`——
`Attorney Docket Number 066964-8034.U800
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`I] That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months priorto the filing of the
`information disclosure statement. See 37 CFR 1.97(e) (1).
`
`OR
`
`I] That no item of information contained in the information disclosure statement was cited in a communication from a
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months priorto the filing ofthe information disclosure
`statement. See 37 CFR 1.97(e) (2).
`
`I] See attached certification statement.
`
`I] Fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`X None
`
`SIGNATURE
`
`A signature ofthe applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for
`the form of the signature.
`
`Name/Print
`
`Kenneth H. Ohriner
`
`Date <YYYY—MM-DD)
`
`Registration Number
`
`31646
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit
`by the public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122
`and 37 CFR 1.14. This collection is estimated to take 1 hourto complete, including gathering, preparing and submitting the
`completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the
`amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, US Patent and Trademark Office, US Department of Commerce, PO. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for
`Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`66964-8034.USOO/134613923.1
`
`ALL REFERENCES CONSEDEEEE EXCEPT WHERE LINED THROUGH.
`
`IE.G.G/
`
`